Heron CFO exercises 25,229 RSUs; shares withheld
Heron Therapeutics EVP and Chief Financial Officer Ira Duarte reported equity compensation activity involving restricted stock units that settled into common stock on July 30 and 31, 2026.
Rhea-AI Filing Summary
Heron Therapeutics EVP and Chief Financial Officer Ira Duarte reported equity compensation activity involving restricted stock units that settled into common stock on July 30 and 31, 2026. In total, 25,229 RSUs converted into an equal number of common shares, while 7,176 shares were withheld at $0.50 per share in transactions reported under code F for payment of exercise price or tax liability. The RSUs include a 216,562-unit grant awarded on January 30, 2026 that vests in 16 equal quarterly installments beginning one quarter after the grant date, as well as an earlier grant from January 31, 2025 with the same 16-installment vesting structure.
Positive
- None.
Negative
- None.
Insider Trade Summary
25,229 shares exercised/converted
Exercise
6 txns
Insider
Duarte Ira
Role
EVP, Chief Financial Officer
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Exercise | Restricted Stock Units F3 | 11,694 | $0.00 | $0.00 |
| Exercise | Common Stock F1 | 11,694 | -- | -- |
| Exercise Price or Tax Liability | Common Stock | 3,326 | $0.50 | $2K |
| Exercise | Restricted Stock Units F2 | 13,535 | $0.00 | $0.00 |
| Exercise | Common Stock F1 | 13,535 | -- | -- |
| Exercise Price or Tax Liability | Common Stock | 3,850 | $0.50 | $2K |
Holdings After Transaction:
Restricted Stock Units — 306,436 contracts (Direct);
Common Stock — 281,899 shares (Direct)
Footnotes (3)
- F1. Each restricted stock unit represents a contingent right to receive one share of common stock.
- F2. On January 30, 2026 (the "Date of Grant"), the Reporting Person was granted 216,562 RSUs which vest upon the following time-based vesting schedule: the RSUs vest in 16 equal quarterly installments beginning one quarter after the Date of Grant.
- F3. The restricted stock units vest in 16 equal installments beginning one quarter after the date of grant (January 31, 2025).
Key Figures
RSUs converted: 25,229 shares
Shares withheld: 7,176 shares
Withholding price: $0.5000 per share
+2 more
5 metrics
RSUs converted
25,229 shares
Total restricted stock units exercised or converted into common stock on July 30–31, 2026
Shares withheld
7,176 shares
Common shares withheld in code F transactions for exercise price or tax liability
Withholding price
$0.5000 per share
Price applied to common shares withheld under code F transactions
RSU grant size
216,562 RSUs
Restricted stock units granted to Ira Duarte on January 30, 2026
Vesting installments
16 installments
RSU grants vest in 16 equal (quarterly) installments beginning one quarter after grant
Key Terms
Restricted Stock Units, Exercise or conversion of derivative security, Payment of exercise price or tax liability by delivering or withholding securities, time-based vesting schedule, +1 more
5 terms
Restricted Stock Units financial
"Each restricted stock unit represents a contingent right to receive one share of common stock."
Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.
Exercise or conversion of derivative security financial
"transaction_code_description: Exercise or conversion of derivative security"
Payment of exercise price or tax liability by delivering or withholding securities financial
"transaction_code_description: Payment of exercise price or tax liability by delivering or withholding securities"
time-based vesting schedule financial
"granted 216,562 RSUs which vest upon the following time-based vesting schedule"
Date of Grant financial
"On January 30, 2026 (the "Date of Grant"), the Reporting Person was granted 216,562 RSUs"
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What insider activity did Heron Therapeutics (HRTX) report for CFO Ira Duarte?
Heron Therapeutics reported that CFO Ira Duarte converted 25,229 restricted stock units into common shares on July 30–31, 2026. In connection with these settlements, 7,176 shares were withheld at $0.50 per share to satisfy obligations reported under code F.
How many restricted stock units did HRTX CFO Duarte have in the January 30, 2026 grant?
On January 30, 2026, CFO Ira Duarte was granted 216,562 restricted stock units. According to the award terms, these RSUs vest in 16 equal quarterly installments, starting one quarter after the grant date, creating periodic conversions into common stock.
What does the code F transaction mean in the HRTX Form 4 for Ira Duarte?
Code F indicates shares used for payment of exercise price or tax liability by delivering or withholding securities. Duarte had 7,176 common shares withheld at $0.50 per share in such transactions related to the RSU settlements on July 30 and 31, 2026.
Were Ira Duarte’s HRTX transactions open‑market buys or sells?
The reported transactions involve RSU vesting and settlement, plus share withholding under code F, rather than open‑market purchases or sales. RSUs converted into 25,229 common shares, with 7,176 of those shares withheld to cover obligations tied to the awards.
What vesting schedule applies to Ira Duarte’s HRTX restricted stock units?
Duarte’s RSU grants described here vest in 16 equal installments, beginning one quarter after their respective grant dates (including a 216,562-unit grant dated January 30, 2026). Each vested unit delivers one share of Heron Therapeutics common stock upon settlement.
AI-generated analysis. How Rhea-AI works. Not financial advice.
